Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice

Virus Research

Volumn 91, Issue 2, 2003, Pages 255-259

  Jones, L D ^a   Bennett, A M ^b   Moss, S R ^a   Gould, E A ^a   Phillpotts, R J ^b  

^a CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Cytotoxic lymphocytes; Immunity; Venezuelan equine encephalitis

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENCEPHALOMYELITIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS GENE; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANIMALS; CELLS, CULTURED; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; HAPLOTYPES; IMMUNIZATION; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRAL PROTEINS; VIRAL VACCINES;

EQUIDAE; VACCINIA VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0037311461     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00275-7     Document Type: Article

References (34)

1. Alevizatos A., McKinney R.W., Feigin R.D. Live, attenuated Venezuelan equine encephalomyelitis vaccine. Am. J. Trop. Med. Hyg. 16:1967;762-768.
2. Bennett A.M., Lescott T.L., Phillpotts R.J. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Viral Immunol. 11:1998;109-117.
3. Bennett A.M., Elvin S.J., Wright A.J., Jones S.M., Phillpotts R.J. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine. Vaccine. 19:2000;337-347.
4. Berge T.O., Banks I.S., Tiggert W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 73:1961;209-218.
5. Breslauer F.K.J., Bloker H., Markey L.A. Predicting DNA duplex stability from base sequence. Proc. Natl. Acad. Sci. 83:1986;3746-3750.
6. Casamassima A.C., Hess L.W., Marty A. TC83 Venezuelan encephalitis exposure during pregnancy. Teratology. 36:1987;287-289.
7. Charles P.C., Brown K.W., Davis N.L., Hart M.K., Johnston R.E. Mucosal immunity induced by parenteral immunisation with a live attenuated Venezuelan equine encephalomyelitis vaccine candidate. Virology. 228:1997;153-160.
8. Cole F.E., May S.W., Eddy G.A. Inactivated with Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus. Appl. Microbiol. 27:1974;150-153.
9. Garcia-Tomayo J. Effecto teratogenico del virus de la encefalitis equina Venezolana, una revision del problema. Invest. Clin. 33:1992;81-86.
10. Greenway T.E., Eldridge J.H., Ludwig G., Staas J.K., Smith J.F., Gilley R.M., Michalek S.M. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Vaccine. 16:1998;1314-1323.
11. Griffin D.E., Johnson R.T. Role of the immune response in recovery from Sindbis encephalitis in mice. J. Immunol. 118:1977;1070-1075.
12. Hart M.K., Pratt W., Panello F., Tamariello R., Dertzbaugh M. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in Balb/c but not C3H/HeN mice. Vaccine. 118:1997;71-75.
13. Hirsch R.L., Griffin D.E. The pathogenesis of Sindbis virus infection in athymic nude mice. J. Immunol. 123:1979;1215-1218.
14. Hirsch R.L., Griffin D.E., Johnson R.T. Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infect. Immun. 23:1979;320-324.
15. Jahrling P.B., Stephenson E.H. Protective efficacies of live-attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J. Clin. Microbiol. 19:1984;429-431.
16. Johnson K.M., Martin D.H. Venezuelan equine encephalitis. Adv. Vet. Sci. Comp. Med. 18:1974;79-116.
17. Johnston R.E., Peters C.J. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. third ed. 1995;843-898 Lippincott-Raven Publishers, Philadelphia-NewYork.
18. Jones L.D., Chuma R., Hails T., Williams S., Roy P. The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants. J. Gen. Virol. 77:1996;997-1003.
19. Kierzek F.S.M., Jaeger J.A., Sugimoto N., Caruthers M.H., Neilson T., Turner D. Improved free-energy parameters for predictions of RNA duplex stability. Proc. Natl. Acad. Sci. 83:1986;9373-9377.
20. Kinney R.M., Esposito J.J., Johnson B.J.B., Roehrig J.T., Mathews J.H., Barrett A.D.T., Trent D.W. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J. Gen. Virol. 69:1988;3005-3015.
21. Kinney R.M., Johnson B.J.B., Welch J.B., Tsuchiya K.R., Trent D.W. The full length sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology. 170:1989;19-30.
22. Linn M.L., Mateo L., Gardner J., Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognise a cross-reactive epitope from the capsid protein and can eliminate virus from persistenly infected macrophages. J. Virol. 72:1998;5146-5153.
23. Makuch R.S., Pitmann P.R., Cannon T.L., Gibbs P.H., Manifico J., Peters C.J. A 15 year review (1976-1990) of the safety and immunigenicity of VEE live, attenuated TC-83 and formalin-inactivated, C-84 vaccines. Am. J. Trop. Med. Hyg. 97:(4S):1992;100.
24. Mathews J.H., Roherig J.T. Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J. Immunol. 129:1982;2763-2767.
25. Offitt P.A., Boyle D.B., Both G.W., Hill N.L., Svoboda N.M., Cunningham S.L., Jenkins R.J., MaCrae M.A. Outer capsid protein VP7 is recognised by cross-reactive rotavirus-specific, cytotoxic T-lymphocytes. Virology. 184:1991;563-568.
26. Phillpotts R.J., Wright A.W. TC-83 vaccine protects against disease produced by airborne or subcutaneous infection with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus. Vaccine. 17:1998;982-988.
27. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine. 14:1996;337-343.
28. Rivas F., Diaz L.A., Cardenas V.M., Daza E., Bruzon L., Alcala A., De la Hoz O., Carceres F.M., Aristizabal G., Martinez J.W., Revelo D., De la Hoz F., Boshell J., Camacho T., Calderon L., Olana V.A., Villarreal L.I., Roselli D., Alvarez G., Ludwig G., Tsai T. Epidemic Venezuelan encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 175:1997;828-832.
29. Roehrig J.T., Hunt A.R., Kinney R.M., Mathews J.T. In vitro mechanisms of monoclonal antibody neutralisation of alphaviruses. Virology. 165:1988;66-73.
30. Rothbard J.B., Taylor W.R. A sequence pattern common to T cell epitopes. EMBO J. 7:1988;93-100.
31. Sambrook J., Fritch E.F., Maniatis T. Molecular Cloning - A Laboratory Manual. second ed. 1989;Cold Spring Harbor Laboratory Press, New York.
32. Shiu S.Y.W., Reid H.W., Gould E.A. Louping ill virus envelope protein expressed by recombinant baculovirus and vaccinia virus fails to stimulate protective immunity. Virus Res. 26:1992;213-229.
33. Strauss J.H., Strauss E.G. The alphaviruses: gene expression, replication and evolution. Microbiol. Rev. 58:1994;491-562.
34. Laboratory safety for arborviruses and certain other viruses of vertebrates. Am. J. Trop. Med. Hyg. 29:1980;1359-1381.